Who is sponsoring NCT04999189?

NCT04999189 is sponsored by University Maribor.

What drugs are being tested in NCT04999189?

Interventions in NCT04999189: Mobile app forDiabetes (Tessera Multimedia, 2020).

What condition does NCT04999189 study?

NCT04999189 studies Type 2 Diabetes, Diabetes Mellitus, Type 2, Disease, Chronic, Self-Care, Health Behavior, Mobile Apps, Mobile Phone Use.

Is NCT04999189 still recruiting?

NCT04999189 is currently status unknown. Last updated 10 August 2021.

Last reviewed 2021-08-10 · How we verify

NCT04999189

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Using a Mobile Application for Type 2 Diabetes Self-care

Status unknown NA Last updated 10 August 2021

What this trial tests

NA trial testing Mobile app forDiabetes (Tessera Multimedia, 2020) in Type 2 Diabetes in 380 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 December 2022

1 December 2022

Quick facts

Lead sponsor	University Maribor
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	380
Start date	1 September 2021
Primary completion	1 December 2022
Estimated completion	1 December 2022

Drugs / interventions tested

Mobile app forDiabetes (Tessera Multimedia, 2020)

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Disease, Chronic — all drugs for Disease, Chronic →
Self-Care — all drugs for Self-Care →

Sponsor

University Maribor

Who can join

18 and older, any sex, with Type 2 Diabetes or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the research is to evaluate and test the usefulness of the mobile application forDiabetes to improve the self-care of individuals with diabetes type 1. The investigators want to obtain the missing evidence from the field of application operation and their impact on individuals' self-care and study the acceptance of applications among healthcare staff, which plays an essential role in patient education.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Impact of Mobile Health Use on the Self-care of Patients With Type 2 Diabetes: Protocol for a Randomized Controlled Trial.
Gosak L, Pajnkihar M, Stiglic G. · · 2022 · cited 3× · PMID 35713944 · DOI 10.2196/31652

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other University Maribor trials

Trials by the same sponsor.

NCT07200518 — Effect of Probiotics After Neurosurgery · NA · recruiting
NCT06755307 — Probiotics for Diaper Dermatitis · NA · recruiting
NCT06226948 — Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases · NA · completed
NCT07398014 — The New Possibility of Treating Overactive Bladder With Radiofrequency · NA · completed
NCT05879393 — The Multistrain Probiotic OMNi-BiOTiC® Active for Upper Respiratory Tract Infections in Older People · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04999189 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Maribor
Last refreshed: 10 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04999189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing